发明授权
US06395898B1 Trans-glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
失效
用于合成(2R,2-α-R,3a)-2- [1-(3,5-双(三氟甲基)苯基)乙氧基] -3-(4-氟苯基)-1,4 恶嗪
- 专利标题: Trans-glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
- 专利标题(中): 用于合成(2R,2-α-R,3a)-2- [1-(3,5-双(三氟甲基)苯基)乙氧基] -3-(4-氟苯基)-1,4 恶嗪
-
申请号: US09878043申请日: 2001-06-08
-
公开(公告)号: US06395898B1公开(公告)日: 2002-05-28
- 发明人: James M. McNamara , Matthew M. Zhao
- 申请人: James M. McNamara , Matthew M. Zhao
- 主分类号: C07D26532
- IPC分类号: C07D26532
摘要:
The present invention is concerned with novel processes for the preparation of (2R, 2-alpha-R, 3a)-2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy-3-(4-fluorophenyl)-1,4-oxazine. This compound is useful as an intermediate in the synthesis of compounds which possess pharmacological activity.
公开/授权文献
信息查询